Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

480.73 +1.70 (+0.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vertex Pharmaceuticals

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
43 44 Next >
Is Vertex Pharmaceuticals Stock a Buy Now?
It's got upcoming catalysts, strong earnings, and a solid base of sales, too. 
Via The Motley Fool
Why CRISPR Therapeutics Stock Is Jumping Today
Analysts continue to like this gene-editing stock. 
Via The Motley Fool
Analyst Expectations for Vertex Pharmaceuticals's Future
Via Benzinga
2 Top Biotech Stocks to Buy in August
Both companies are performing exceedingly well. 
Via The Motley Fool
3 Top Healthcare Stocks to Buy for August
Shares of Humana, Vertex Pharmaceuticals, and Idexx Laboratories have all increased by at least 20% so far this year. 
Via The Motley Fool
3 Fantastic Growth Stocks to Buy in August
These stocks could be poised to soar. 
Via The Motley Fool
2 Nasdaq 100 Stocks That Are Surefire Buys in August and 1 to Avoid
Two Nasdaq 100 components are plain-as-day bargains, while another Nasdaq 100 stock could struggle to live up to lofty expectations. 
Via The Motley Fool
This Is Arguably the Single Best Stock to Buy Right Now
This stock appears to be in a league of its own. 
Via The Motley Fool
Tech Leader Vertex Pharmaceuticals Beats And Raises, But Shares Inch Lower
The company ended the quarter with $12.6 billion in cash and equivalents. 
Via Investor's Business Daily
Market Rally Under Pressure As Yields Soar; Amazon, ELF, Caterpillar Are Earnings Winners: Weekly Review
Amazon, ELF and CAT were earnings winners, but there were big losers too. 
Via Investor's Business Daily
Vertex Pharma Raises Annual Forecast On Strong Uptake For Cystic Fibrosis Drug, Analysts Says Investors' Focus On Non-CF Pipeline
Vertex Pharmaceuticals Inc's (NASDAQ: VRTX) Q2 sales increased 14% to $2.49 billion, beating the consensus of $2.41 bill 
Via Benzinga
Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript
VRTX earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Peering Into Vertex Pharmaceuticals's Recent Short Interest
Via Benzinga
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $2,500 Today
Via Benzinga
Nasdaq, S&P 500 Futures Pullback After Strong July; Why This Analyst Recommends Staying Fully Invested
Via Benzinga
Rising Stars, Falling Trends: July's Industry ETF Winners And Losers
Via Benzinga
Better Big Biotech Buy: Vertex vs. Biogen
These companies have a track record of billion-dollar earnings. 
Via The Motley Fool
These 2 Stocks Are Heading for a Big Moment. Time to Buy?
Both stocks have climbed in the double digits this year. 
Via The Motley Fool
3 Biotech Stocks to Buy Before the Breakout
Explosive growth and rapid innovation lie ahead for these three biotechnology stocks, making them the ones to watch. 
Via InvestorPlace
Could Vertex Pharmaceuticals Stock Help You Retire a Millionaire?
The biotech is currently firing on all cylinders, but can it last? 
Via The Motley Fool
3 Biotech Stocks You Better Be Buying on Each and Every Dip
Biotech companies can bring about life-changing innovations. We've created a list to help you find the best biotech stocks out there. 
Via InvestorPlace
If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names
These are the best biotech stocks that investors can invest in. That's because they are sector leaders that can make you a millionaire. 
Via InvestorPlace
2 No-Brainer Cathie Wood Stocks to Buy Right Now
Vertex Pharmaceuticals and Pfizer should be stellar long-term buys. 
Via The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023
These three undervalued biotech stocks could have plenty of room to run if their efforts to push out promising pipeline drugs are successful. 
Via InvestorPlace
Barron's Weekend Stock Picks: Barbie Bonanza, Vertex's Promising Drug And Tesla Doubts
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. 
Via Benzinga
The Best Stocks to Invest $5,000 in Right Now
Investors won't have to worry about overpaying for any of these stocks. 
Via The Motley Fool
B of A Securities Maintains Buy Rating for Vertex Pharmaceuticals: Here's What You Need To Know
Via Benzinga
Is Now a Good Time to Buy CRISPR Therapeutics?
CRISPR shares have climbed more than 40% this year. 
Via The Motley Fool
My Take: 4 Strong Growth Stocks to Buy This Week
The key to growth stocks is finding ones with significant tailwinds. 
Via The Motley Fool
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
43 44 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.